Agency Forms Undergoing Paperwork Reduction Act Review, 52047-52049 [2017-24417]
Download as PDF
<![CDATA[
52047
Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices
Proposed Project
Rapid Response Suicide Investigation
Data Collection—New—National Center
for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is frequently called upon to
respond to urgent requests from one or
more external partners (e.g., local, state,
territory, and tribal health authorities;
other federal agencies; local and state
leaders; schools; or other partner
organizations) to conduct investigations
of suicide. Supporting rapid
investigations to inform the
implementation of effective suicide
prevention strategies is one of the most
important ways CDC can serve to
protect and promote the health of the
public. Prior to this information
collection request, CDC had collected
data for a suicide investigation via the
OMB-approved Emergency Epidemic
Investigations (EEI) generic information
collection plan (OMB Control Number
0920–1011; expiration date 3/31/2020),
which supported data collections for
Epi-Aid investigations. However, this
mechanism is no longer available for
rapid suicide responses due to the
narrowing in scope of that generic. CDC
requests a three-year approval of a
generic information collection plan that
allows for rapid response to urgent CDC
assistance requests to investigate an
apparent and unexplained potential
cluster or increase in suicidal behavior.
the unique circumstances of the Rapid
Response Suicide Investigation Data
Collections.
Requests for assistance may include a
state, county, community, or vulnerable
population. Suicide rates are increasing
across age-groups and vulnerable
populations, include, but are not limited
to, youth, middle-aged adults, active
duty service personnel, veterans, and
American Indian/Alaska Native
communities. Investigations likely will
often require collection of information
from 10 or more respondents. The data
analytic approach for the Rapid
Response Suicide Investigation Data
Collection will vary and depend on the
objectives and methods of the
investigation.
Multiple analytical strategies are
likely to be employed in a single
investigation. This may include
descriptive analyses, logistic regression,
and temporal and spatial cluster
analyses. The goal of the analyses is to
inform suicide prevention strategies by
understanding (a) significant increases
in fatal or nonfatal suicidal behavior; (b)
the risk factors associated with trends of
fatal or nonfatal suicidal behavior; (c)
the groups most affected (e.g., gender,
age, location in community or state);
and (d) current risk and protective
factors and prevention opportunities.
The total estimated annualized burden
for this collection is 1,000 hours. The
only cost to respondents will be time
spent responding to the surveys.
CDC designed the Rapid Response
Suicide Investigation Data Collections
specifically to inform the
implementation of prevention strategies
in a state, county, community, or
vulnerable population where a possible
suicide cluster or increasing trend has
been observed. CDC will not use this
generic information collection plan to
conduct research studies or to collect
data designed to draw conclusions
about the United States or areas beyond
the defined geographic location or
vulnerable population that is the focus
of the investigation.
These public health data are used by
external partners (e.g., local, state,
territory, and tribal health authorities;
other federal agencies; local and state
leaders; schools; or other partner
organizations) to identify, prioritize, and
implement strategies to prevent suicidal
behavior and suicide.
Rapid Response Suicide Investigation
Data Collections methods will vary and
depend on the unique circumstances of
the urgent and rapid response and
objectives determined by CDC.
Investigations may use descriptive and/
or cohort- or case-control designs. Data
collection modes may include: (a)
Archival record abstraction; (b) face-toface interview; (c) telephone interview;
(d) web-based questionnaire; (e) selfadministered questionnaire; and (f)
focus groups. CDC will likely employ
multiple data collection designs and
modes in a single investigation. The
subpopulation will vary and depend on
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Type of respondents
Form name
Rapid Response Suicide Investigation Data Collection Participants.
Rapid Response Suicide Investigation Data Collection Instruments.
2,000
1
30/60
1,000
Total ...........................................
...........................................................
........................
........................
........................
1,000
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–24404 Filed 11–8–17; 8:45 am]
Centers for Disease Control and
Prevention
[30Day–18–17ZX]
Agency Forms Undergoing Paperwork
Reduction Act Review
BILLING CODE 4163–18–P
sradovich on DSK3GMQ082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Childhood
Blood Lead Surveillance (CBLS) and
Adult Blood Lead Epidemiology and
VerDate Sep<11>2014
17:32 Nov 08, 2017
Jkt 244001
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
Surveillance (ABLES)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on April 6,
2017 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
E:\FR\FM\09NON1.SGM
09NON1
52048
Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to OMB@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW.,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
sradovich on DSK3GMQ082PROD with NOTICES
Proposed Project
Childhood Blood Lead Surveillance
(CBLS) and Adult Blood Lead
Epidemiology and Surveillance
(ABLES)—New—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Over the past several decades, there
have been substantial efforts in
environmental lead abatement,
improved protection from occupational
lead exposure, and a reduction in the
prevalence of population blood-lead
levels (BLLs) over time. U.S. population
BLLs have substantially decreased over
the last four decades. For example, the
CDC has reported the 1976–1980 U.S.
BLL mean in children, 6 months to 5
years, as 16.0 micrograms per deciliter
(mg/dL); and among adults, 18 to 74
years, as 14.1 mg/dL. More recently, the
CDC reported the 2009–2010 U.S. BLL
geometric means among children, 1 to 5
years, and among adults, 20 years and
older, as 1.2 mg/dL. Despite the
VerDate Sep<11>2014
17:32 Nov 08, 2017
Jkt 244001
reduction in the overall population BLL
over four decades, lead exposures
continue to occur at unacceptable levels
for individuals in communities and
workplaces across the nation. As of
2015, both the National Center for
Environmental Health (NCEH) and the
National Institute for Occupational
Safety and Health (NIOSH) define
elevated BLLs as greater than or equal
to 5 mg/dL for individuals of all ages.
NCEH is leading this new three-year
information collection project that
covers two CDC information collections,
one for childhood blood lead
surveillance by NCEH and another for
adult blood lead surveillance by NIOSH.
Thus, blood lead surveillance over the
human lifespan is covered under this
single ICR, specifically for children, less
than 16 years, through the NCEH
Childhood Blood Lead Surveillance
(CBLS) Program, and for adults, 16 years
and older, through the NIOSH Adult
Blood Epidemiology and Surveillance
(ABLES) Program.
The goal of the NCEH CBLS Program
is to support blood lead screening and
to promote primary prevention of
exposure to lead. Also, the CBLS
Program supports secondary prevention
of adverse health effects when lead
exposures occur in children through
improved program management and
oversight in respondent jurisdictions.
This new information collection
project will cover the NCEH Fiscal Year
2017 (FY17) three-year cooperative
agreement, titled ‘‘Lead Poisoning
Prevention—Childhood Lead Poisoning
Prevention—financed partially by
Prevention and Public Health Funds’’
(Funding Opportunity Announcement
[FOA] No. CDC–RFA–EH17–1701–
PPHF17). The first year of this new
program, with 48 awardees, will run
concurrently with the final and fourth
budget year for ‘‘PPHF 2014: Lead
Poisoning Prevention—Childhood Lead
Poisoning Prevention—financed solely
by 2014 Prevention and Public Health
Funds’’ (FOA No. CDC–RFA–EH14–
1408PPHF14). The information
collection project titled ‘‘Healthy Homes
and Lead Poisoning Surveillance
System (HHLPSS)’’ (OMB Control
Number 0920–0931; expiration date
05/31/2018) is funded by an existing
four-year FY14 cooperative agreement
with up to 40 awardees. Returning
awardees will submit childhood blood
lead surveillance data under HHLPSS
for the final year of the FY14 program,
and then will continue to submit data
for the second year of the FY17 program
under this new project.
New FY17 awardees will submit
CBLS data only under this new
information collection project. NCEH is
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
requesting approval for the following
differences for the new program: (1)
Clarifying awardees’ procedures for data
delivery into the CBLS system; and (2)
revising the CBLS Variables forms to
remove healthy homes variables. Based
on available FY17 funds, NCEH is also
requesting the following: (3) Increasing
the number of potential NCEH
respondents from 40 to 48; and (4)
increasing the NCEH annual time
burden from 640 to 760 hours.
On a quarterly basis, CDC anticipates
that up to 47 CBLS respondents will
submit quarterly text files of individual
blood lead test records. Based on
experience, CDC also anticipates that
one awardee will report quarterly
aggregated records to CBLS. The
estimated annual time burden for NCEH
CBLS is 760 hours.
The goal of the NIOSH Adult Blood
Lead Epidemiology and Surveillance
(ABLES) Program is to build state
capacity for adult blood lead
surveillance programs to measure trends
in adult blood lead levels and to prevent
lead over-exposures. CDC is taking this
opportunity to provide the public with
a detailed description of the NIOSH
ABLES information collection.
Previously, ABLES was included but
not fully described in the HHLPSS
information collection request (OMB
Control Number 0920–0931; expiration
date 05/31/2018). To correct for this
omission, NIOSH is requesting approval
for the following: (1) Providing a
detailed description of the authority and
scope of the ABLES information
reporting procedures; (2) adding 40
NIOSH respondents to the burden table;
and (3) adding 280 hours for the NIOSH
annual time burden. Once approved in
this new information collection request,
CDC will submit a revision request to
remove the description of the ABLES
Program from the existing HHLPSS
project.
On an annual basis, and in addition
to a brief narrative report of notable lead
surveillance activities in the past year,
NIOSH gives ABLES respondents the
option to report either individual adult
case blood lead results or aggregate
counts of adult blood lead test results.
NIOSH anticipates that 80 percent of
state programs will send case records
and 20 percent will send aggregate
records. The estimated annual time
burden for NIOSH ABLES is 280 hours.
In total, CDC is requesting approval
for a total annual time burden of 1,040
hours. CDC defines respondents as State
or local health departments, or their
Bona Fide agents, with lead poisoning
prevention programs.
E:\FR\FM\09NON1.SGM
09NON1
52049
Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Type of respondents
Form name
State or Local Health Departments, or their
Bona Fide Agents.
State or Local Health Departments, or their
Bona Fide Agents.
State or Local Health Departments, or their
Bona Fide Agents.
Childhood Blood Lead Surveillance (CBLS
Variables—Text Files.
CBLS—Aggregate Records Form ..................
47
4
4
1
4
2
Adult Blood Lead Epidemiology and Surveillance (ABLES) Case Records Form and
Brief Narrative Report.
ABLES Aggregate Records Form and Brief
Narrative Report.
32
1
8
8
1
3
State or Local Health Departments, or their
Bona Fide Agents.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–24417 Filed 11–8–17; 8:45 am]
Dated: November 3, 2017.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2017–24388 Filed 11–8–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
[60Day–18–18AF]
Proposed Data Collection Submitted
for Public Comment and
Recommendations—Assessments To
Inform Program Refinement for HIV,
Other STD, and Pregnancy Prevention
Among Middle and High-School Aged
Youth
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice; Correction.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) requested
publication of a document in the
Federal Register. Document 2017–
24317, Proposed Data Collection
Submitted for Public Comment and
Recommendations—Assessments to
Inform Program Refinement for HIV,
other STD, and Pregnancy Prevention
among Middle and High-School Aged
Youth, has been scheduled to publish
on November 8, 2017. The document
provided the incorrect docket number
(CDC–2018–0093).
FOR FURTHER INFORMATION CONTACT:
Leroy Richardson, 1600 Clifton Road,
MS D–74, Atlanta, GA 30333; telephone
(404) 639–4965; email: omb@cdc.gov.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
Correction
Correct the docket number to read:
[Docket No. CDC–2017–0093]
VerDate Sep<11>2014
18:37 Nov 08, 2017
Jkt 244001
[30Day–18–17AMO]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessment of
Ill Worker Policies Study’’ to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 14,
2017 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW.,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Assessment of Ill Worker Policies
Study—New—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is requesting a new
three-year OMB clearance to conduct
information collection entitled
‘‘Assessment of Ill Worker Policies
Study.’’ CDC’s National Center for
Environmental Health implements the
Environmental Health Specialists
Network (EHS-Net) program, which
conducts studies to identify and
understand environmental factors
associated with foodborne illness
outbreaks and other food safety issues
(e.g., ill food workers). These data are
E:\FR\FM\09NON1.SGM
09NON1
]]>Agencies
[Federal Register Volume 82, Number 216 (Thursday, November 9, 2017)]
[Notices]
[Pages 52047-52049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24417]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-17ZX]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Childhood Blood Lead Surveillance (CBLS)
and Adult Blood Lead Epidemiology and Surveillance (ABLES)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on April 6, 2017 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget
[[Page 52048]]
is particularly interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to OMB@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Childhood Blood Lead Surveillance (CBLS) and Adult Blood Lead
Epidemiology and Surveillance (ABLES)--New--National Center for
Environmental Health (NCEH), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Over the past several decades, there have been substantial efforts
in environmental lead abatement, improved protection from occupational
lead exposure, and a reduction in the prevalence of population blood-
lead levels (BLLs) over time. U.S. population BLLs have substantially
decreased over the last four decades. For example, the CDC has reported
the 1976-1980 U.S. BLL mean in children, 6 months to 5 years, as 16.0
micrograms per deciliter ([mu]g/dL); and among adults, 18 to 74 years,
as 14.1 [mu]g/dL. More recently, the CDC reported the 2009-2010 U.S.
BLL geometric means among children, 1 to 5 years, and among adults, 20
years and older, as 1.2 [mu]g/dL. Despite the reduction in the overall
population BLL over four decades, lead exposures continue to occur at
unacceptable levels for individuals in communities and workplaces
across the nation. As of 2015, both the National Center for
Environmental Health (NCEH) and the National Institute for Occupational
Safety and Health (NIOSH) define elevated BLLs as greater than or equal
to 5 [mu]g/dL for individuals of all ages.
NCEH is leading this new three-year information collection project
that covers two CDC information collections, one for childhood blood
lead surveillance by NCEH and another for adult blood lead surveillance
by NIOSH. Thus, blood lead surveillance over the human lifespan is
covered under this single ICR, specifically for children, less than 16
years, through the NCEH Childhood Blood Lead Surveillance (CBLS)
Program, and for adults, 16 years and older, through the NIOSH Adult
Blood Epidemiology and Surveillance (ABLES) Program.
The goal of the NCEH CBLS Program is to support blood lead
screening and to promote primary prevention of exposure to lead. Also,
the CBLS Program supports secondary prevention of adverse health
effects when lead exposures occur in children through improved program
management and oversight in respondent jurisdictions.
This new information collection project will cover the NCEH Fiscal
Year 2017 (FY17) three-year cooperative agreement, titled ``Lead
Poisoning Prevention--Childhood Lead Poisoning Prevention--financed
partially by Prevention and Public Health Funds'' (Funding Opportunity
Announcement [FOA] No. CDC-RFA-EH17-1701-PPHF17). The first year of
this new program, with 48 awardees, will run concurrently with the
final and fourth budget year for ``PPHF 2014: Lead Poisoning
Prevention--Childhood Lead Poisoning Prevention--financed solely by
2014 Prevention and Public Health Funds'' (FOA No. CDC-RFA-EH14-
1408PPHF14). The information collection project titled ``Healthy Homes
and Lead Poisoning Surveillance System (HHLPSS)'' (OMB Control Number
0920-0931; expiration date 05/31/2018) is funded by an existing four-
year FY14 cooperative agreement with up to 40 awardees. Returning
awardees will submit childhood blood lead surveillance data under
HHLPSS for the final year of the FY14 program, and then will continue
to submit data for the second year of the FY17 program under this new
project.
New FY17 awardees will submit CBLS data only under this new
information collection project. NCEH is requesting approval for the
following differences for the new program: (1) Clarifying awardees'
procedures for data delivery into the CBLS system; and (2) revising the
CBLS Variables forms to remove healthy homes variables. Based on
available FY17 funds, NCEH is also requesting the following: (3)
Increasing the number of potential NCEH respondents from 40 to 48; and
(4) increasing the NCEH annual time burden from 640 to 760 hours.
On a quarterly basis, CDC anticipates that up to 47 CBLS
respondents will submit quarterly text files of individual blood lead
test records. Based on experience, CDC also anticipates that one
awardee will report quarterly aggregated records to CBLS. The estimated
annual time burden for NCEH CBLS is 760 hours.
The goal of the NIOSH Adult Blood Lead Epidemiology and
Surveillance (ABLES) Program is to build state capacity for adult blood
lead surveillance programs to measure trends in adult blood lead levels
and to prevent lead over-exposures. CDC is taking this opportunity to
provide the public with a detailed description of the NIOSH ABLES
information collection. Previously, ABLES was included but not fully
described in the HHLPSS information collection request (OMB Control
Number 0920-0931; expiration date 05/31/2018). To correct for this
omission, NIOSH is requesting approval for the following: (1) Providing
a detailed description of the authority and scope of the ABLES
information reporting procedures; (2) adding 40 NIOSH respondents to
the burden table; and (3) adding 280 hours for the NIOSH annual time
burden. Once approved in this new information collection request, CDC
will submit a revision request to remove the description of the ABLES
Program from the existing HHLPSS project.
On an annual basis, and in addition to a brief narrative report of
notable lead surveillance activities in the past year, NIOSH gives
ABLES respondents the option to report either individual adult case
blood lead results or aggregate counts of adult blood lead test
results. NIOSH anticipates that 80 percent of state programs will send
case records and 20 percent will send aggregate records. The estimated
annual time burden for NIOSH ABLES is 280 hours.
In total, CDC is requesting approval for a total annual time burden
of 1,040 hours. CDC defines respondents as State or local health
departments, or their Bona Fide agents, with lead poisoning prevention
programs.
[[Page 52049]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State or Local Health Departments, or Childhood Blood Lead 47 4 4
their Bona Fide Agents. Surveillance (CBLS
Variables--Text Files.
State or Local Health Departments, or CBLS--Aggregate Records 1 4 2
their Bona Fide Agents. Form.
State or Local Health Departments, or Adult Blood Lead 32 1 8
their Bona Fide Agents. Epidemiology and
Surveillance (ABLES)
Case Records Form and
Brief Narrative Report.
State or Local Health Departments, or ABLES Aggregate Records 8 1 3
their Bona Fide Agents. Form and Brief
Narrative Report.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-24417 Filed 11-8-17; 8:45 am]
BILLING CODE 4163-18-P
